🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Israel shares lower at close of trade; TA 25 down 0.04%

Published 22/01/2017, 15:00
Israel shares lower at close of trade; TA 25 down 0.04%
TEVA
-
TA35
-
TEREAL
-
DLEKG
-
ICL
-
ILCO
-
TABLUTECHGLB
-
BIOMED
-
OPK
-
PRGO
-

Investing.com – Israel equities were lower at the close on Sunday, as losses in the Biomed, Technology and Real Estate sectors propelled shares lower.

At the close in Tel Aviv, the TA 25 lost 0.04% to hit a new 1-month low.

The biggest gainers of the session on the TA 25 were Israel Corp (TA:ILCO), which rose 3.23% or 2250 points to trade at 72000 at the close. ICL Israel Chemicals Ltd (TA:ICL) added 2.87% or 48 points to end at 1722 and Delek Group (TA:DLEKG) was up 1.14% or 950 points to 84110 in late trade.

Biggest losers included OPKO Health Inc (TA:OPK), which lost 2.52% or 84 points to trade at 3244 in late trade. Perrigo (TA:PRGO) declined 2.13% or 620 points to end at 28480 and Teva (TA:TEVA) shed 1.86% or 240 points to 12640.

Declining stocks outnumbered rising ones by 215 to 139 and 87 ended unchanged on the Tel Aviv Stock Exchange.

In commodities trading, Crude oil for March delivery was up 2.05% or 1.07 to $53.19 a barrel. Meanwhile, Brent oil for delivery in March rose 2.38% or 1.29 to hit $55.45 a barrel, while the February Gold contract rose 0.67% or 8.00 to trade at $1209.50 a troy ounce.

USD/ILS was down 0.46% to 3.7997, while EUR/ILS fell 0.05% to 4.0688.

The US Dollar Index was down 0.33% at 100.77.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.